| | | DACARBAZINE IMPURITY A
CAS:4656-86-4
Formula: C4H3N5O
> 95%
4656-86-4
2-Azahypoxanthine; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one; 1,5-Dihydro-4H-Imidazo[4,5-d]-1,2,3-triazin-4-one; 3,7-Dihydro-4H-imidazo[4,5-d]-v-triazin-4-one DACN(TOS2)
CAS:1797508-57-6
Formula: C21H24N2O4S2
BADC-01787
N,N'-bis(p-toluenesulfonyl)-4,8-diazacyclononyne; 1,5-Ditosyl-2,3,4,5,6,9-hexahydro-7,8-didehydro-1H-1,5-diazonine DACTYLFUNGIN A
CAS:146935-35-5
Formula: C41H64O9
BBF-00778
2H-Pyran-2-one, 3-(4-deoxy-beta-xylo-hexopyranosyl)-4-hydroxy-6-(2-hydroxy-7-(hydroxymethyl)-1,1,5,9,11,13,17,19-octamethyl-3,5,13,15,17-heneicosapentaenyl)- DACTYLFUNGIN B
CAS:146935-36-6
Formula: C41H64O9
BBF-00779
4H-Pyran-4-one, 3-(4-deoxy-beta-xylo-hexopyranosyl)-2-hydroxy-6-(2-hydroxy-7-(hydroxymethyl)-1,1,5,9,11,13,17,19-octamethyl-3,5,13,15,17-heneicosapentaenyl)- DACTYLOCYCLINE A
CAS:125622-12-0
Formula: C31H40ClN3O13
BBF-00780
7-chloro-4-(dimethylamino)-3,4a,10,12,12a-pentahydroxy-6-((4-(hydroxyamino)-5-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-8-methoxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide DACTYLOCYCLINE B
CAS:125622-13-1
Formula: C31H38ClN3O14
BBF-00781
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-6-((2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-alpha-L-arabino-hexopyranosyl)oxy)-, (4R-(4alpha, DACTYLOCYCLINE D
CAS:146064-00-8
Formula: C33H42ClN3O14
BBF-00782
6-((4-(acetoxyamino)-5-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-chloro-4-(dimethylamino)-3,4a,10,12,12a-pentahydroxy-8-methoxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Dagrocorat hydrochloride
CAS:1044535-61-6
Formula: C29H30ClF3N2O2
1044535-61-6
PF-00251802 hydrochloride; 2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(trifluoromethyl)-, hydrochloride (1:1), (4bS,7R,8aR)-; (4bS,7R,8aR)-4b-Benzyl-7-hydroxy-N-(2-methyl-3 DAMASCENONE
CAS:23696-85-7
Formula: C13H18O
>98%
23696-85-7
beta-Damascenone; 1-(2,6,6-Trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one; 2-Buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-; Damascenone; Damascenone (natural); EINECS 245-833-2; FEMA No. 3420; 4-(2,6,6-Trimethylcyclohexa-1,3-die DANMELITTOSIDE
CAS:20633-72-1
Formula: C15H22O10
>98%
20633-72-1
(2S,3R,4S,5S,6R)-2-[[(1S,4aS,5R,7aR)-4a,5-dihydroxy-7-(hydroxymethyl)-5,7a-dihydro-1H-cyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Dapagliflozin 3-O-+¦-D-Glucuronide
CAS:1351438-75-9
Formula: C27H33ClO12
GëÑ95%
1351438-75-9
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3-O-+¦-D-glucopyranuronosyl-D-glucitol; D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3-O-+¦-D-glucopyranuronosyl-, (1S)-; (2S,3S,4S,5R,6R)-6-(((2S,3S, DAPAGLIFLOZIN OPEN SUGAR IMPURITY
Formula: C21H27ClO7
Dapagliflozin open sugar impurity; 1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; (2S,3R,4R,5R)-1-(4-Chloro-3-(4-ethoxybenzyl)phenyl)hexane-1,2,3,4,5,6-hexaol; Dapagliflozin ring opening impurity; (1R,2S,3R,4R)-1-(4-Chloro-3-(4 DAPAGLIFLOZIN PROPANEDIOL HYDRATE
CAS:960404-48-2
Formula: C24H35ClO9
>98%
B0084-463704
Dapagliflozin (2S)-1,2-propanediol, hydrate; Dapagliflozin propylene glycol hydrate; D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1); D-Glucitol, 1,5-anhydro Dapagliflozin-[d7]DISCONTINUED
CAS:1204219-51-1
Formula: C21H18D7ClO6
BLP-020650
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxy-D5-benzyl)phenyl)-6-(hydroxymethyl-D2)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-(ethoxy-D5)phenyl)methyl-D2)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (1S)-1, DAPHMACRINE
CAS:19775-48-5
Formula: C32H49NO4
NP0458
Daphmacrine; 19775-48-5; C32H49NO4; [(1S,2S,5S,8R)-1,5-dimethyl-8-[2-[(1S,2R,3S,7R,10S,13S,14R)-1-methyl-14-propan-2-yl-12-azapentacyclo[8.6.0.02,13.03,7.07,12]hexadecan-2-yl]ethyl]-7-oxo-6-oxabicyclo[3.2.1]octan-2-yl] acetate; ZINC10005833 DAPHMACROPODINE
CAS:39729-21-0
Formula: C32H51NO4
97.5%
NP0391
(1S,2S,5S,7R,8R)-7-Hydroxy-8-{2-[(1S,2R,3S,7R,10S,13S,14R)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.02,13.03,7.07,12]hexadec-2-yl]ethyl}-1,5-dimethyl-6-oxabicyclo[3.2.1]oct-2-yl acetate DAPHNICYCLIDIN D
CAS:385384-24-7
Formula: C23H27NO4
NP0162
Daphnicyclidine D;1,12-Methanopyrano[4',3',2':1,8]azuleno[4,5-a]indolizine-2-carboxylic acid, 3,4,6,7,7a,8,10,11,12,13,13a,13b-dodecahydro-11,13b-dimethyl-14-oxo-, methyl ester, (7aS,9S,11S,12R,13aR,13bS)- DAPHNICYCLIDIN F
CAS:385384-26-9
Formula: C23H27NO5
NP0293
Daphnicyclidine F;1,12-Methanopyrano[2',3',4':8,1]azuleno[4,5-a]indolizine-2-carboxylic acid, 3,4,6,7,7a,8,10,11,12,13,13a,13b-dodecahydro-12-hydroxy-11,13b-dimethyl-14-oxo-, methyl ester, (7aS,9R,11R,12S,13aR,13bS)- DAPHNICYCLIDIN H
CAS:385384-29-2
Formula: C23H29NO5
NP0187
Daphnicyclidine H;4H-1,11-Methanoazuleno[4,5-a]indolizine-2-carboxylic acid, 5,6,6a,7,9,10,11,12,12a,12b-decahydro-13-hydroxy-3-(2-hydroxyethyl)-10,12b-dimethyl-4-oxo-, methyl ester, (6aS,8S,10S,11R,12aR,12bS)- DAPHNICYCLIDIN I
CAS:1467083-10-8
Formula: C22H26N2O3
>95%
NP0230
(7aS,11S,12R,13aR,13bS)-15-amino-11,13b-dimethyl-3,4,6,7,7a,8,10,11,12,13,13a,13b-dodecahydro-1H,5H-12,14-(metheno)pyrano[4',3':1,2]azuleno[4,5-a]indolizine-1,5-dione DAPHNILONGERANIN A
CAS:874201-05-5
Formula: C23H29NO4
97.5%
NP0471
Daphnilongeranin A; 874201-05-5; Methyl (1s,2s,3r,5r,6s,10s)-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[11.6.1.11,5.02,10.03,8.017,20]henicosa-13(20),17-diene-18-carboxylatedaphnilongeranins AZINC96023819 DAPHNILONGERANIN C
CAS:750649-07-1
Formula: C22H29NO3
98%
NP0235
Daphnilongeranin C; 750649-07-1; (1r,2s,3r,5r,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.11,5.02,10.03,8.016,19]icos-13(19)-ene-17-carboxylic Acid; daphnilongeranins C; ZINC96023636 DAPHNILONGERIDINE
CAS:922522-15-4
Formula: C32H51NO4
95%
NP0440
Daphnilongeridine; 922522-15-4; [(1S,2S,5S,7R,8R)-7-hydroxy-1,5-dimethyl-8-[2-[(1S,2R,3R,7R,10S,11R,13S,14R)-1-methyl-14-propan-2-yl-12-azapentacyclo[8.6.0.02,13.03,7.07,11]hexadecan-2-yl]ethyl]-6-oxabicyclo[3.2.1]octan-2-yl] acetate DAPHNIYUNNINE A
CAS:881388-87-0
Formula: C23H31NO3
98%
NP0346
1H-11,12c-Methanocyclopent[1,8]azuleno[4,5-a]indolizine-2-carboxylic acid, 2,2a,3,4,5,6,6a,7,9,10,11,12,12a,12b-tetradecahydro-13-oxo-10,12b-dimethyl-, methyl ester, (2R,2aR,6aS,8S,10S,11R,12aR,12bS,12cR)- DAPHNIYUNNINE B
CAS:881388-88-1
Formula: C21H29NO3
NP0253
4H-11,12c-Methanoazuleno[4,5-a]indolizine-4,13-dione, 1,2,5,6,6a,7,9,10,11,12,12a,12b-dodecahydro-3-(2-hydroxyethyl)-10,12b-dimethyl-, (6aS,8S,10S,11R,12aR,12bS,12cS)- DARUTIGENOL
CAS:5940-00-1
Formula: C20H34O3
0.975
NP1432
(1R)-1-[(2S,4a+¦,8a+¦)-2,3,4,4a,4b,5,6,7,8,8a,9,10-Dodecahydro-7+¦-hydroxy-2,4b+¦,8,8-tetramethylphenanthren-2-yl]-1,2-ethanediol; DAUN02
CAS:290304-24-4
Formula: C41H44N2O20
>98%
BADC-00043
Daun 02; Daun-02; (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 2,3,6-trideoxy-3-[({[4-(+¦-D-galactopyranosyloxy)-3-nitrobenzyl]oxy}carbonyl)amino]-+¦-L-lyxo-hexopyranoside; 5,12-Naphthacenedione DAUNOMYCIN
CAS:20982-41-6
Formula: C21H14O7
GëÑ95%
20982-41-6
8-Acetyl-6,10,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 8-Acetyl-6,10,11-trihydroxy-1-methoxytetracene-5,12-dione; 8-Acetyl-5,12-dihydro-6,10,11-trihydroxy-1-methoxynaphthacene-5,12-dione; 5,12-Naphthacenedione, 8-acetyl-6,10,11-trihyd DAUNOMYCINONE
CAS:21794-55-8
Formula: C21H18O8
GëÑ95%
B0709-195144
Daunorubicin Impurity A; (8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Daunorubicin EP Impurity A; (+)-Daunomycinone; NSC 109531; (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-m Daunorubicin 4'-O-+¦-D-Glucoside
CAS:229314-80-1
Formula: C33H37NO16
229314-80-1
(1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-4-O-+¦-D-glucopyranuronosyl-+¦-L-lyxo-hexopyranoside; 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-4-O-+¦-D-gluc Daunorubicin 4'-O-+¦-D-Glucoside Sodium Salt
CAS:229314-76-5
Formula: C33H36NNaO16
229314-76-5
(2S,3S,4S,5R,6S)-6-(((2S,3S,4S,6R)-6-(((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)-4-amino-2-methyltetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate sodium DAUNORUBICIN IMPURITY 2
CAS:63700-24-3
Formula: C22H18F3N3O10
63700-24-3
2,3,6-Trideoxy-1,4-bis-O-(4-nitrobenzoyl)-3-[(trifluoroacetyl)amino]-+¦-L-lyxo-hexopyranose; +¦-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate); (2S,4S,5S,6S)-6-methyl-4-(2,2,2-trifluoroacetamid Daunorubicin Impurity 3 Dihydrochloride
CAS:99457-12-2
Formula: C32H38N2O11.2HCl
99457-12-2
Daunorubicin Impurity 3 DiHCl; 5,12-Naphthacenedione, 9-acetyl-7,9-bis[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-, dihydrochloride, (7S-cis)- DAUNORUBICIN IMPURITY 7
CAS:131086-18-5
Formula: C31H38BrNO11
131086-18-5
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-diethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; Doxorubicin Impurity 15; (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyra DAUNORUBICIN IMPURITY 8
CAS:1010447-40-1
Formula: C34H35NO10
GëÑ95%
1010447-40-1
(8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; (8S,10S)-8-Acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-+¦-L-lyxo- DAUNORUBICIN-[13C,D3]
Formula: C26[13C]H26D3NO10
85% (CP); 98% atom D; 98% atom 13C
BLP-003512
Daunorubicin-13C,d3; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione-3C,d3 DAUNORUBICINOL
CAS:28008-55-1
Formula: C27H31NO10
>95%
B0709-469824
Daunorubicin Impurity B ((1S)-isomer); 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-((1S)-1-hydroxyethyl)-1-methoxy-, (8S,10S)-; 13-Dihydrodaunorubicin; Duborimycin; Daunorubicinol formate salt (mixture of diastereoisomers)
Formula: C28H33NO12
95%
(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((S)-1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione formate; 13-Dihydrodaunorubicin formate; Duborimycin formate; Leu DAUNORUBICINOL HYDROCHLORIDE
CAS:28008-53-9
Formula: C27H32ClNO10
GëÑ95%
B0709-004063
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, hydrochloride, [8S-[8+¦,8(R*),10+¦]]-; 13-Dihydrodaunorubicin Hydrochloride; Duborimycin Hydro Daunorubicinol TFA
Formula: C27H31NO10.C2HF3O2
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, trifluoroacetic acid, [8S-[8+¦,8(R*),10+¦]]-; 13-Dihydrodaunorubicin trifluoroacetic acid; Dub DAURICINE
CAS:524-17-4
Formula: C38H44N2O6
>98%
NP0049
4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenol; 4-[((1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl)methy Dazucorilant
CAS:1496508-34-9
Formula: C29H22F4N4O3S
1496508-34-9
{(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)benzene-1-sulfonyl]-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl}(pyridin-2-yl)methanone; (R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4,5,6,7,8-hexahydro-4a DBA-DM4
CAS:905449-84-5
Formula: C42H60ClN3O12S2
BADC-00704
4-[[5-[[(2S)-1-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methyl DBCO-PEG1-NHS ESTER
CAS:2228857-34-7
Formula: CGééGéêHGééGéçNGéâOGéç
98%
BP-501490
(2,5-dioxopyrrolidin-1-yl) 3-[2-[[4-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxobutanoyl]amino]ethoxy]propanoate; 2,5-dioxopyrrolidin-1-yl 3-[2-(4-{2-azatricyclo[10.4.0.0,hexadeca-1(16),4,6,8,12,14-hexaen-1 DBCO-PEG2-PFP ESTER
CAS:2304558-23-2
Formula: C32H27F5N2O6
98%
R01-0420
(2,3,4,5,6-pentafluorophenyl) 3-[2-[2-[[4-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxobutanoyl]amino]ethoxy]ethoxy]propanoate DBCO-PEG4-DBCO
CAS:2182601-68-7
Formula: C48H50N4O8
>98.0%
BADC-01077
N-[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]-3-[2-[2-[2-[3-[[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propa DBCO-PEG4-GGFG-DMEA-PNU159682
Formula: C82H97N9O25
BADC-01421
N-[20-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-17,20-dioxo-4,7,10,13-tetraoxa-16-azaicosan-1-oyl]glycylglycyl-L-phenylalanyl-N-methyl-N-{2-[methyl({2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-4-{[(1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-met DBCO-PEG5-DBCO
CAS:2363130-04-3
Formula: C50H54N4O9
0.95
BPG-4218
DBCO-PEG5-DBCO; 2363130-04-3; AKOS040743210; BP-22450; N,N'-bis(3-{2-azatricyclo[10.4.0.0,hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl}-3-oxopropyl)-4,7,10,13,16-pentaoxanonadecanediamide; HY-140302; CS-0114783; F77651 DBCO-PEG5-NHS ESTER
CAS:2144395-59-3
Formula: C36H43N3O11
>98.0%
BADC-01073
4,7,10,13,16-Pentaoxa-19-azatricosanoic acid, 23-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-20,23-dioxo-, 2,5-dioxo-1-pyrrolidinyl ester DBCO-PEG9-DBCO
CAS:2353409-50-2
Formula: CGéàGéêHGéçGéÇNGéäOGéüGéâ
98%
BP-501601
N,N'-bis(3-{2-azatricyclo[10.4.0.0,hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl}-3-oxopropyl)-4,7,10,13,16,19,22,25,28-nonaoxahentriacontanediamide DBET1
CAS:1799711-21-9
Formula: C38H37ClN8O7S
98%
B1370-285214
(6S)-4-(4-chlorophenyl)-N-[4-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]butyl]-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide DBET57
CAS:1883863-52-2
Formula: C34H31ClN8O5S
GëÑ95%
1883863-52-2
dBET 57; dBET-57; 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethyl]-2,3,9-trimethyl-, (6S)-; 2-[(6S)-4-(4-Chlorophenyl DC 81
CAS:81307-24-6
Formula: C13H14N2O3
BBF-02802
Antibiotic DC 81; (+)-1,2,3,11a-Tetrahydro-8-hydroxy-7-methoxy-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one; 7-Methoxy-8-hydroxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one; 8-hydroxy-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrol DC-CHOLESTEROL HCL
Formula: C32H57ClN2O2
0.95
BPG-3620
DC-Chol; DC-Chol (hydrochloride); DC-Cholesterol; 166023-21-8; DC-cholesterol hydrochloride; DC-Cholesterol HCl; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cy DC44
CAS:1354787-77-1
Formula: C27H36F5N3O8S
BADC-01436
Pentafluorophenyl 17-oxo-21-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13-tetraoxa-16-azahenicosan-1-oate; 4,7,10,13-Tetraoxa-16-azaheneicosan-1-oic acid, 21-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-y DC92-B
CAS:116988-30-8
Formula: C42H52N2O12
>98%
BBF-02804
DC 92B; 4H-Anthra(1,2-b)pyran-4,7,12-trione, 11-hydroxy-5-methyl-8-(2,3,6-trideoxy-3-(dimethylamino)-beta-D-arabino-hexopyranosyl)-10-(2,3,6-trideoxy-3-(dimethylamino)-5-C-hydroxy-3-C-methylhexopyranosyl)-2-(3,3',3'-trimethyl(2,2'-bioxiran) DCU
CAS:116-52-9
Formula: C5H6Cl6N2O3
95%
116-52-9
1,3-bis(1-hydroxy-2,2,2-trichloroethyl)urea;1,3-bis(1-hydroxy-2,2,2-trichloroethyl)urea[qr];1,3-bis(2,2,2-trichloro-1-hydroxyethyl)-ure;1,3-bis(2,2,2-trichloro-1-hydroxyethyl)urea;1,3-bis(2,2,2-trichloro-1-hydroxyethyl)urea[qr];cragdcu-73w DDAO
CAS:118290-05-4
Formula: C15H11Cl2NO2
118290-05-4
9H-(1,3-dichloro-9,9-dimethylacridin-2-one); 7-Hydroxy-9H-1,3-dichloro-9,9-dimethylacridin-2-one; 1,3-dichloro-7-hydroxy-9,9-dimethylacridin-2(9H)-one; 1,3-dichloro-7-hydroxy-9,9-dimethyl-9H-acridin-2-one; 7-Hydroxy-9H-(1,3-dichloro-9,9-dim DE-1-((2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-2-YL)METHYL)-1H-1,2,4-TRIAZOLE ITRACONAZOLE SULFATE
CAS:765882-88-0
Formula: C23H29N5O6S
BB068582
[(2S,3S)-3-[4-[4-[4-(4-Methoxyphenyl)piperazin-1-yl]phenyl]-5-oxo-1,2,4-triazol-1-yl]butan-2-yl] hydrogen sulfate; De-1-((2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-1H-1,2,4-triazole Itraconazole Sulfate DE-BOC CABAZITAXEL
CAS:1638286-64-2
Formula: C40H49NO12
BB068635
De-boc Cabazitaxel; [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
